ADCT

1.2851.15%
JI

Jose I. Carmona

Chief Financial Officer

Mr. Jose I. Carmona, also known as Pepe, MBA serves as CFO at ADC Therapeutics SA since December 19, 2022. He serves as Director at Senda Biosciences, Inc. since 2022. Mr. Carmona serves as a Director at HotSpot Therapeutics, Inc, since July 2022. Mr. Carmona was Chief Financial Officer of Rubius Therapeutics, Inc. since October 1, 2020 until 2022 and also served as its Principal Accounting Officer and Treasurer since October 1, 2020. He served as Chief Financial Officer and Treasurer at Radius Health, Inc. since May 15, 2017 until September 24, 2020. He served as Senior Vice President at Radius Health, Inc. since May 15, 2017 until June 2020. He joined Radius one month after the FDA approval of TYMLOS® in 2017 and he has been instrumental in helping Radius advance from a development company to a commercial company with a late stage pipeline. Mr. Carmona served as Chief Financial Officer of Innocoll Holdings plc (formerly known as Innocoll AG) since September 1, 2015 until May 1, 2017 and served as its Member of Management Board since October 7, 2015 until March 16, 2016. Mr. Carmona has experience applying his extensive management skills toward the financial operations of commercial-stage companies. He served as Chief Financial Officer of Alcon Europe, Middle East & Africa from 2013 to 2015, a division of Novartis and he held numerous financial management positions with increasing responsibility within Novartis. Before joining Novartis in 2003, Mr. Carmona held senior management positions for several divisions of Proctor and Gamble in Latin America. Mr. Carmona received his B.S. in Industrial and Civil Engineering from Universidad Tecnica Federico Santa Maria in Valparaiso, Chile and his MBA from Columbia Business School in New York City.

Positions